background

Filter By Category

Active Pharma Ingredients
Disease Dictionary

Archives

Posted by -

Active Pharma Ingredients / 25 Aug 2026

ANCRIVIROC

Generic Name: ANCRIVIROC

ABSTRACT -

Ancriviroc is an orally bioavailable small-molecule CCR5 antagonist originally investigated as an HIV entry inhibitor. By blocking CCR5, it was designed to prevent CCR5-tropic HIV-1 from entering target immune cells and was also explored in inflammatory disease research.

DOSAGE - 

  • Dosage should be determined only by a qualified healthcare professional.
  • Ancriviroc is not approved for routine clinical use.
  • Clinical dosing was investigational and should not be inferred from related CCR5 antagonists.
  • HIV tropism testing would be required for any CCR5-targeted HIV strategy.

SIDE EFFECTS–

  • Possible side effects include:
  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Fatigue
  • Rash
  • Liver enzyme abnormalities
  • Possible hypersensitivity symptoms

ALLRGIC REACTIONS–

  • Possible allergic reaction symptoms include:
  • Urticaria
  • Pruritic rash
  • Facial swelling
  • Bronchospasm
  • Systemic hypersensitivity symptoms
  • Important: Patients who develop an allergic reaction to Ancriviroc should seek immediate medical attention and inform all future healthcare providers of the allergy.

DRUG INTERACTIONS–

  • CYP3A inhibitors or inducers may alter exposure for CCR5-antagonist class agents.
  • Other antiretrovirals may require careful interaction review.
  • Hepatotoxic medicines may increase liver monitoring requirements.
  • Immunomodulators may alter infection risk.
  • Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, vaccines, and supplements they are using.

PREAUTIONS–

  • Use only in controlled research settings.
  • Monitor liver enzymes and systemic hypersensitivity symptoms.
  • Do not use without confirming appropriateness of CCR5 targeting.
  • Not a substitute for approved antiretroviral therapy.

WARNINGS –

  • Investigational/discontinued agent; not for general HIV treatment.
  • Stop and seek care for rash with systemic symptoms or jaundice.
  • Use only under specialist supervision.
  • Keep out of reach of children.

Have any questions? or Need help Contact us – 022 6163 6163 | support@medicus.com

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

©2026 Copyright. All rights reserved. Powered by . Developed by Hats-Off

Log in with your credentials

Forgot your details?

Feedback